Emergent T-helper 2 profile with high interleukin-6 levels correlates with the appearance of bortezomib-induced neuropathic pain.
Mangiacavalli
Silvia
S
Corso
Alessandro
A
De Amici
Mara
M
Varettoni
Marzia
M
Alfonsi
Enrico
E
Lozza
Alessandro
A
Lazzarino
Mario
M
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009437:Neuralgia / Q000139:chemically induced*; D011446:Prospective Studies; D011719:Pyrazines / Q000009:adverse effects*; D018418:Th2 Cells / Q000187:drug effects*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D015850:Interleukin-6; D011719:Pyrazines; D000069286:Bortezomib